Cotellic® (cobimetinib) : Mises en garde concernant les risques d’hémorragie et de rhabdomyolyse - Lettre aux professionnels de santé (ANSM - 26/04/2017)
Powered by
eZ Publish™ CMS Open Source Web Content Management
. Copyright © 1999-2014
eZ Systems AS
(except where otherwise noted). All rights reserved.